Press Releases & Presentations

 
(Swipe to view full table)
  Date Title and Summary View

Oct 16, 2017

Accelerate Diagnostics Schedules Call to Review Third Quarter 2017 Results for November 2nd
TUCSON, Ariz., Oct. 16, 2017 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc. announced today it will host a conference call on Thursday, November 2, 2017 to review its third quarter 2017 financial results and commercial progress. President and Chief Executive Officer, Lawrence Mehren, joined by Steve Reichling, Chief Financial Officer, will...Read more

Sep 13, 2017

Plaintiffs Dismiss Class Action Appeal Against Accelerate Diagnostics
TUCSON, Ariz., Sept. 13, 2017 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc. announced today that the United States Court of Appeals for the Ninth Circuit signed an order dismissing the plaintiffs' Appeal of their class action lawsuit filed against Accelerate and certain of its executives. Shortly before the Appeal was scheduled to be argued, t...Read more

Aug 3, 2017

Accelerate Diagnostics Reports Q2 2017 Financial Results, Doubles Revenue Generating Placements
TUCSON, Ariz., Aug. 03, 2017 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc. today announced preliminary financial results for the quarter ending June 30, 2017.  The company further reported signed agreements for 265 instruments year to date; contracts for customer evaluations have grown to 220 instruments while revenue generating placements hav...Read more

Jul 31, 2017

Accelerate Diagnostics Welcomes Dr. Romney Humphries as Chief Scientific Officer
TUCSON, Ariz., July 31, 2017 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc. announced today the addition of Romney Humphries, PhD, D(ABMM), M(ASCP) to its executive management team as Chief Scientific Officer. Dr. Romney Humphries comes to Accelerate from UCLA Medical Center where she was the Section Chief for Clinical Microbiology and the...Read more

Jul 18, 2017

Accelerate Diagnostics Schedules Call to Review Second Quarter 2017 Results for August 3rd
TUCSON, Ariz., July 18, 2017 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc. announced today it will host a conference call on Thursday, August 3, 2017 to discuss its second quarter 2017 financial results and commercial progress. President and Chief Executive Officer, Lawrence Mehren, joined by Steve Reichling, Chief Financial Officer, will...Read more

Jun 7, 2017

Accelerate Diagnostics to Present at the 37th Annual Growth Stock Conference hosted by William Blair & Company
TUCSON, Ariz., June 07, 2017 (GLOBE NEWSWIRE) -- Lawrence Mehren, president and chief executive officer of Accelerate Diagnostics, will present at the 37th Annual Growth Stock Conference hosted by William Blair & Company in Chicago on Wednesday, June 14, 2017, at 04:00 PM Central Time. A live webcast of the presentation will be accessible fr...Read more

May 30, 2017

Accelerate Diagnostics announces sizeable release of data at ASM Microbe 2017
TUCSON, Ariz., May 30, 2017 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc. today announced that new data from 11 healthcare institutions covering more than 1,200 samples will be presented at the upcoming annual meeting of the American Society for Microbiology - ASM Microbe in New Orleans, LA. The data comes from external studies that evalu...Read more

May 15, 2017

Accelerate Diagnostics Announces Closing of $79.3 Million Upsized Offering
TUCSON, Ariz., May 15, 2017 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc. (Nasdaq:AXDX) announced the closing of its previously announced underwritten public offering of 2,750,000 shares of its common stock today, upsized from the original share offering of 2,500,000 shares of common stock, at a previously disclosed public offering price of $2...Read more

May 9, 2017

Accelerate Diagnostics Announces Pricing of Upsized Public Offering of Common Stock
TUCSON, Ariz., May 09, 2017 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc. (Nasdaq:AXDX) today announced the pricing of an underwritten public offering of 2,750,000 shares of its common stock, upsized from the original share offering of 2,500,000 shares of common stock, at a price to the public of $28.85 per share. All of the shares are being s...Read more

May 8, 2017

Accelerate Diagnostics Announces Proposed Public Offering of Common Stock
TUCSON, Ariz., May 08, 2017 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc. (Nasdaq:AXDX) today announced that it has commenced an underwritten public offering of 2,500,000 shares of its common stock. All of the shares are being offered by Accelerate Diagnostics. In addition, Accelerate Diagnostics expects to grant the underwriters of the offeri...Read more
1
2
3
...
7
Next Last

= add release to Briefcase
NASDAQ: AXDX
$ 20.60
0.00
(0.00%)
4:00 PM ET on Oct 17, 2017
Day High: N/A
Day Low:  N/A
Volume:    200
Delayed ~20 min., by eSignal.

Want to receive investor-related news and updates?

Join our mailing list

Other updates